Maria Carlucci

Dr. Maria Carlucci


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MPMercedes Pérez-Recalde
Mercedes Pérez-Recalde
MMMaría C. Matulewicz
María C. Matulewicz
CPCarlos A. Pujol
Carlos A. Pujol
MCMaria Carlucci
Maria Carlucci

1 June 2011 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
CMCecilia G. Msc Mateu
Cecilia G. Msc Mateu
MRMercedes Perez Msc Recalde
Mercedes Perez Msc Recalde
MAMaría C. Msc Artuso
María C. Msc Artuso
GHGladys Hermida
Gladys Hermida
FLFlorencia N. Msc Linero
Florencia N. Msc Linero
MCMaria Carlucci
Maria Carlucci
Background: Antiviral therapy against herpes simplex virus based on sulfated polysaccharides, like carrageenans, represents a new alternative for genital herpes infections treatment and arises the concern about the appearance of resistant viral populations. Methods: We characterized the F strain of herpes simplex virus-1 passaged in the presence of a natural carrageenan isolated from the red seaweed Gigartina skottbergii in view of the virulence for mice of isolated viral clones. Results: Viral clones (syn14-1 and syn17-2) showed a syncytial phenotype and a mild resistance to carrageenan, heparin, acyclovir, and brivudine. Both clones were avirulent for BALB/c mice when inoculated intravaginally, whereas F strain produced high mortality. Attenuation correlated with low levels of TNF-α, interleukin-6, and IFN-γ in vaginal lavages although virus titers were similar to those obtained for F strain. On the contrary, they showed a marked virulence when inoculated intranasally leading to a generalized spreading of virus. Conclusions: Results confirm the hypothesis that selection of herpes simplex virus-1 with a carrageenan in vitro leads to the emergence of variants with a differential virulence when compared to the original virus. This finding should be addressed when an antiviral therapy against genital herpes infection employing a natural carrageenan is under consideration.

1 July 2011 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
MCMaria Carlucci
Maria Carlucci
EDE.B. Damonte
E.B. Damonte
LSL.A. Scolaro
L.A. Scolaro

21 January 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MCMayra A. Castañeda Cataña
Mayra A. Castañeda Cataña
AMAndrea P. Rivas Marquina
Andrea P. Rivas Marquina
MTMartín M. Dodes Traian
Martín M. Dodes Traian
MCMaria Carlucci
Maria Carlucci
EDElsa Damonte
Elsa Damonte
CSClaudia Soledad Sepúlveda
Claudia Soledad Sepúlveda
The global spread of viral diseases is a public health issue. Ribavirin (RBV) and mycophenolic acid (MPA) are well-known wide-spectrum antiviral agents. The present study evaluated the potential of bovine serum albumin (BSA) nanoparticles (NPs) as a vehicle to improve the efficacy of molecules with antiviral activity. The results demonstrated that NPs offer a promising strategy for the delivery of antiviral drugs, improving their stability and reducing toxicity compared to free agents. BSA-based NPs effectively encapsulated hydrophilic molecules such as MPA and water-soluble compounds such as RBV, achieving encapsulation efficiencies of 10% and 20%, respectively. The purified NPs exhibited a particle size between 60 and 100 nm and did not show toxicity at the evaluated concentrations. In cellular viral infection models against Zika virus (ZIKV), Junín virus (JUNV), vesicular stomatitis virus (VSV) and herpes simplex virus (HSV-1), the BSA-based NPs loaded with MPA or RBV demonstrated antiviral properties superior to those of non-encapsulated agents, as well as 100- and 200-fold effective dose reductions, respectively. These findings clearly indicate the potential of BSA NPs as a novel platform for the development of safer and more efficient antiviral therapies.

1 December 2016 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
MAM.C. Artuso
M.C. Artuso
JRJ.S. Roldán
J.S. Roldán
LSL.A. Scolaro
L.A. Scolaro
MCMaria Carlucci
Maria Carlucci

1 June 2014 in Microbial Pathogenesis
Verified
Journal Article
Open access
MAM. Carolina Artuso
M. Carolina Artuso
FLFlorencia N. Linero
Florencia N. Linero
SGSilvina Gazzaniga
Silvina Gazzaniga
LSLuis A. Scolaro
Luis A. Scolaro
CPCarlos A. Pujol
Carlos A. Pujol
MCMaria Carlucci
Maria Carlucci
Immune evasion strategies are important for the onset and the maintenance of viral infections. Many viruses have evolved mechanisms to counteract or suppress the host immune response. We have previously characterized two syncytial (syn) variants of Herpes simplex 1 (HSV-1) strain F, syn14-1 and syn17-2, obtained by selective pressure with a natural carrageenan. These variants showed a differential pathology in vaginal and respiratory mucosa infection in comparison with parental strain. In this paper, we evaluated the modulation of immune response in respiratory mucosa by these HSV-1 variants. We observed altered levels of Tumor Necrosis Factor-alpha and Interleukin-6 in lungs of animals infected with the syn14-1 and syn17-2 variants compared with the parental strain. Also, we detected differences in the recruitment of immune cells to the lung in syn variants infected mice. Both variants exhibit one point mutation in the sequence of the gene of glycoprotein D detected in the ectodomain of syn14-1 and the cytoplasmic tail of syn17-2. Results obtained in the present study contribute to the characterization of HSV-1 syn variants and the participation of the cellular inflammatory response in viral pathogenesis. (c) 2014 Elsevier Ltd. All rights reserved.